10x Genomics (NAS: TXG)

The AI engine Fit Assessment

Beta

10x Genomics develops advanced DNA sequencing technology and innovative tools for analyzing biological systems, enabling researchers to uncover complex cellular interactions and gene expression patterns in various fields, including oncology and immunology. Their product portfolio includes instruments, consumables, and software designed to enhance scientific discovery.

Blurb

10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.

HQ Location

United States

Founded

2012

Employees

1001 - 5000

Total funding raised

$3.90B

Last Funding Event

Post-IPO Equity, January 1, 2020

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Genomic Data Analysis

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.